• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthmedicine

Joe Rogan’s highly questionable ivermectin COVID-19 ‘cure’ may be lethal. It’s also catching on around the world

Sophie Mellor
By
Sophie Mellor
Sophie Mellor
Down Arrow Button Icon
Sophie Mellor
By
Sophie Mellor
Sophie Mellor
Down Arrow Button Icon
September 2, 2021, 6:38 AM ET

Ivermectin is an antiparasitic pill mainly used to deworm horses and cows. It is also, according to podcast star Joe Rogan, a great way to treat COVID-19.

Even before the endorsement from Rogan, who recently came down with COVID-19 and treated it with a cocktail of drugs unproven to be effective against the illness, ivermectin had been growing in popularity. In places like Brazil, Bolivia, Peru, and South Africa—along with the U.S.—people were using it to self-medicate against COVID-19.

Google searches for ivermectin are at an all-time high. Searches for ivermectin jumped alongside other at-home remedies like “hydroxychloroquine” at the start of the pandemic in March 2020, but while the Trump-backed hydroxychloroquine fell out of favor, ivermectin maintained its popularity. Prescriptions for ivermectin jumped to more than 88,000 in the week ended Aug. 13, and some pharmacists have even reported shortages of the drug.

But as with many unproven medicines, it can have fatal consequences.

Calls to poison control centers about ivermectin exposures have risen fivefold over the baseline in July, according to CDC researchers who used data from the American Association of Poison Control Centers.

Mississippi’s health department even issued an alert in August saying 70% of recent calls to the state poison control center had come from people who over-ingested ivermectin from livestock supply stores.

Such dangerous effects from self-prescription have prompted Merck, the manufacturer of the drug, to come out and say there was no scientific basis for ivermectin to be used as treatment against COVID-19 and the Food and Drug Administration to caution against ingestion of the medicine, warning that “using the drug ivermectin to treat COVID-19 can be dangerous and even lethal.”

Beyond ivermectin’s potential dangers, the drug also appears to offer little benefit in the fight against COVID. Researchers looking into the efficacy of ivermectin as a COVID-19 treatment had to shut down a large 1,300 patient trial because the drug had been no better than a placebo at preventing hospitalizations. Dr. Edward Mills, a professor at McMaster University who led the study, noted the team would have discontinued it earlier were it not for the level of public interest in ivermectin.

Researchers and physicians are particularly worried by people who are seeking out ivermectin to prevent COVID-19 in lieu of getting a vaccine.

But this has not stopped Rogan, the popular podcast host who has already been in hot water for suggesting young, fit people don’t need to get the COVID-19 vaccine.

After announcing a few canceled tour dates owing to his illness, Rogan gave a shout-out to the medicine, saying “a wonderful, heartfelt thank you to modern medicine for pulling me out of this so quickly and so easily.”

https://www.instagram.com/p/CTSsA8wAR2-/

Instagram captioned his post with a short warning: “Some unapproved COVID-19 treatments may cause serious harm.”

Facebook, owner of Instagram, did not respond to requests for comment.

Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.
About the Author
Sophie Mellor
By Sophie Mellor
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

Latest in Health

Photo of Sam Altman
AIHealth
OpenAI launches ChatGPT Health in a push to become a hub for personal health data
By Sharon GoldmanJanuary 7, 2026
4 hours ago
HealthChatGPT
OpenAI suggests ChatGPT play doctor as millions of Americans face spiking insurance costs: ‘In the U.S., ChatGPT has become an important ally’
By Tristan BoveJanuary 7, 2026
6 hours ago
Lonely young woman in office
SuccessWorkplace Wellness
Lonely staff at a major pharmacy chain are being paid $100 to take time off and text a friend—welcome to Sweden’s ‘friendship hour’
By Emma BurleighJanuary 7, 2026
7 hours ago
flu season
PoliticsFlu Season
You’re not just imagining it—this flu season is officially severe with 45 states reporting high or very high activity
By Mike Stobbe and The Associated PressJanuary 6, 2026
1 day ago
rfk
PoliticsVaccines
America’s pediatricians reel as government slashes vaccine requirements for children
By Ali Swenson, Lauran Neergaard and The Associated PressJanuary 5, 2026
2 days ago
Travel & Leisurework-life balance
Experts are divided on how workers should spend their 5-9: Structure is key for productivity, but can lead to burnout
By Jamie Wilde and Morning BrewJanuary 5, 2026
2 days ago

Most Popular

placeholder alt text
Law
Amazon is cutting checks to millions of customers as part of a $2.5 billion FTC settlement. Here's who qualifies and how to get paid
By Sydney LakeJanuary 6, 2026
1 day ago
placeholder alt text
Economy
Mark Cuban on the $38 trillion national debt and the absurdity of U.S. healthcare: we wouldn't pay for potato chips like this
By Nick LichtenbergJanuary 6, 2026
1 day ago
placeholder alt text
Personal Finance
Janet Yellen warns the $38 trillion national debt is testing a red line economists have feared for decades
By Eva RoytburgJanuary 5, 2026
2 days ago
placeholder alt text
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top colleges
By Jake AngeloJanuary 6, 2026
1 day ago
placeholder alt text
Success
The college-to-office path is dead: CEO of the world’s biggest recruiter says Gen Z grads need to consider trade and hospitality jobs that don't even require degrees
By Orianna Rosa RoyleJanuary 6, 2026
1 day ago
placeholder alt text
Success
Blackstone exec says elite Ivy League degrees aren’t good enough—new analysts need to 'work harder' and be nice 
By Ashley LutzJanuary 5, 2026
2 days ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.